IGNACIO ZABALETA: Open Payments
NPI 1033571633 · HOLLYWOOD, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$19,993 in 182 payments from 18 companies in 2025. Trend: 2023 $12,872 · 2024 $14,611 · 2025 $19,993
Speaker / faculty: $8,920Consulting: $6,230Food & beverage: $4,023Travel & lodging: $819
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 33 | $16,879 |
| Neurocrine BioSciences, Inc. | 13 | $393 |
| Janssen Pharmaceuticals, Inc | 17 | $325 |
| ABBVIE INC. | 16 | $314 |
| Bausch Health US, LLC | 12 | $271 |
| Teva Pharmaceuticals USA, Inc. | 22 | $265 |
| Axsome Therapeutics, Inc. | 12 | $227 |
| Indivior Inc. | 8 | $224 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $217 |
| Vanda Pharmaceuticals Inc. | 7 | $188 |
Products named: LYBALVI, INGREZZA, ARISTADA, VRAYLAR, APLENZIN, Auvelity, SUBLOCADE, TRINTELLIX.
Industry payments across FL — which companies pay providers there.
